Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme Post published:March 28, 2022 Post category:News / Research TLN_April2022_p342_354 (pdf) The Lancet Neurology April2022 p342_354 (online) from The Lancet Neurology You Might Also Like Link to Article: Concordance of CSF RT-QuIC across the European Creutzfeldt-Jakob Disease surveillance network May 9, 2022 Podcast: In conversation with… John Collinge March 28, 2022 Link to article: Thirty years after my OE, how long will mad cow disease keep me from giving blood? May 16, 2022
Link to Article: Concordance of CSF RT-QuIC across the European Creutzfeldt-Jakob Disease surveillance network May 9, 2022
Link to article: Thirty years after my OE, how long will mad cow disease keep me from giving blood? May 16, 2022
